| Period Ending | 31-Dec-2011 | 31-Dec-2010 | 31-Dec-2009 | 31-Dec-2008 |
|---|
|
Total Revenue
|
5,683,000
|
7,664,000
|
10,915,000
|
(10,960,000)
| | Cost of Revenue | 672,000 | 3,630,000 | 6,904,000 | (13,020,000) | | |
Gross Profit
|
5,011,000
|
4,034,000
|
4,011,000
|
2,060,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 4,034,000 | 5,865,000 | 9,033,000 | (11,204,000) | | | |
Operating Income or Loss
|
1,649,000
|
1,799,000
|
1,882,000
|
244,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 1,649,000 | 1,799,000 | 1,882,000 | 244,000 |
|
Interest Expense | (807,000) | (789,000) | (599,000) | (838,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | (3,000) | 126,000 | 505,000 | (1,668,000) |
|
Minority Interest | 12,000 | 20,000 | 16,000 |
-
|
|
|
|
Net Income From Continuing Ops | 676,000 | 755,000 | 723,000 | 580,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
688,000
|
775,000
|
739,000
|
580,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|
0.19%